These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24732907)

  • 1. An Interferon-Induced Digital Vasculitis-Like Syndrome: A Case Report.
    Hamidi O; Reiser J; Hasler S
    Am J Ther; 2016; 23(3):e920-5. PubMed ID: 24732907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillaritis associated with interferon-alfa treatment of chronic hepatitis C infection.
    Gupta G; Holmes SC; Spence E; Mills PR
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):937-8. PubMed ID: 11044828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
    Boonyapisit K; Katirji B
    Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.
    Wilson LE; Widman D; Dikman SH; Gorevic PD
    Semin Arthritis Rheum; 2002 Dec; 32(3):163-73. PubMed ID: 12528081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injection site vasculitis in a patient receiving interferon alfa for chronic hepatitis C.
    Christian MM; Diven DG; Sanchez RL; Soloway RD
    J Am Acad Dermatol; 1997 Jul; 37(1):118-20. PubMed ID: 9216535
    [No Abstract]   [Full Text] [Related]  

  • 6. Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis.
    Pompili M; Pizzolante F; Larocca LM; Covino M; Rapaccini GL; Gasbarrini G
    Dig Liver Dis; 2006 May; 38(5):352-4. PubMed ID: 16169782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Saadoun D; Limal N; Sene D; Lidove O; Piette JC
    Arthritis Rheum; 2005 Mar; 52(3):911-5. PubMed ID: 15751068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus associated arthritis in absence of clinical, biochemical and histological evidence of liver disease--responding to interferon therapy.
    Akhtar AJ; Funnyé AS
    Med Sci Monit; 2005 Jul; 11(7):CS37-9. PubMed ID: 15990694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lethal course of chronic hepatitis C, glomerulonephritis, and pulmonary vasculitis unresponsive to interferon treatment.
    Roithinger FX; Allinger S; Kirchgatterer A; Prischl F; Balon R; Haidenthaler A; Knoflach P
    Am J Gastroenterol; 1995 Jun; 90(6):1006-8. PubMed ID: 7771395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].
    Iferkhass S; Elasri F; Chatioui S; Khoyaali A; Bargach T; Reda K; Oubaaz A
    J Fr Ophtalmol; 2015 Jan; 38(1):34-40. PubMed ID: 25533994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged psychosis associated with interferon therapy in a patient with hepatitis C: case study and literature review.
    Cheng YC; Chen CC; Ho AS; Chiu NY
    Psychosomatics; 2009; 50(5):538-42. PubMed ID: 19855041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of myasthenia gravis which developed myasthenic crisis after alpha-interferon therapy for chronic hepatitis C].
    Konishi T
    Rinsho Shinkeigaku; 1996 Aug; 36(8):980-5. PubMed ID: 8958752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
    Naarendorp M; Kallemuchikkal U; Nuovo GJ; Gorevic PD
    J Rheumatol; 2001 Nov; 28(11):2466-73. PubMed ID: 11708420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection].
    Warabi Y; Matsubara S; Mizutani T; Hayashi H
    Rinsho Shinkeigaku; 2004 Sep; 44(9):609-14. PubMed ID: 15515704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C.
    Nagao Y; Kawaguchi T; Ide T; Kumashiro R; Sata M
    Int J Mol Med; 2005 Feb; 15(2):237-41. PubMed ID: 15647837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryoglobulinemic vasculitis with multiple digital necrosis in viral hepatitis.
    Mironiuc A; Comes L; Constantinescu I; Mironiuc C; Bontea D
    Rom J Intern Med; 2008; 46(1):91-5. PubMed ID: 19157277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-alpha and ribavirin.
    Misery L
    J Interferon Cytokine Res; 2002 Aug; 22(8):881-2. PubMed ID: 12396727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
    Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
    J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir.
    Marquez-Azalgara V; Hussaini T; Erb SR; Yoshida EM
    Ann Hepatol; 2014; 13(5):565-7. PubMed ID: 25152991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.